As of 2026-09-13, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (38.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -200.4%.
The range of the Relative Valuation is (35.38) - (42.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 25.9x | 23.3x |
| Forward P/E multiples | 20.3x - 26.2x | 23.4x |
| Fair Price | (35.38) - (42.48) | (38.36) |
| Upside | -192.6% - -211.1% | -200.4% |
| Date | P/E |